Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
5.04
+0.17 (3.60%)
At close: Aug 24, 2026, 4:00 PM EDT
5.10
+0.06 (1.29%)
After-hours: Aug 24, 2026, 6:10 PM EDT
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $8.22 million as of August 24, 2026. Its market cap has decreased by -28.57% in one year.
Market Cap
8.22M
Enterprise Value
3.54M
1-Year Change
-28.57%
Ranking
Category
Stock Price
$5.04
ChartMarket Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.27M to $8.22M, a decrease of -95.83%. That is a compound annual growth rate of -44.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 8.22M | -12.73% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.18% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CNS Pharmaceuticals | 8.52M |
| Xenetic Biosciences | 8.41M |
| Traws Pharma | 8.07M |
| Aprea Therapeutics | 8.06M |
| Azitra | 8.05M |
| Immuron | 7.96M |
| AIM ImmunoTech | 7.87M |
| Acurx Pharmaceuticals | 7.75M |